Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 5
1988 2
1989 4
1990 7
1991 8
1992 14
1993 18
1994 23
1995 64
1996 81
1997 99
1998 131
1999 193
2000 257
2001 350
2002 470
2003 517
2004 529
2005 556
2006 612
2007 669
2008 736
2009 743
2010 717
2011 749
2012 794
2013 859
2014 862
2015 860
2016 857
2017 741
2018 716
2019 694
2020 618
2021 603
2022 534
2023 436
2024 378

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,646 results

Results by year

Filters applied: . Clear all
Page 1
The biology of VEGF and its receptors.
Ferrara N, Gerber HP, LeCouter J. Ferrara N, et al. Nat Med. 2003 Jun;9(6):669-76. doi: 10.1038/nm0603-669. Nat Med. 2003. PMID: 12778165 Review.
Vascular endothelial growth factor (VEGF) is a key regulator of physiological angiogenesis during embryogenesis, skeletal growth and reproductive functions. ...VEGF inhibition is also being tested as a strategy for the prevention of angiogene …
Vascular endothelial growth factor (VEGF) is a key regulator of physiological angiogenesis during embryogenesis, …
VEGFs, receptors and angiogenesis.
Veikkola T, Alitalo K. Veikkola T, et al. Semin Cancer Biol. 1999 Jun;9(3):211-20. doi: 10.1006/scbi.1998.0091. Semin Cancer Biol. 1999. PMID: 10343072 Review.
The vascular endothelial growth factors (VEGFs) and their receptors are prime regulators of both physiological and pathological angiogenesis. The different VEGFs have overlapping but specific roles in controlling the grow …
The vascular endothelial growth factors (VEGFs) and their receptors are prime regulators of both p …
VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
Lohela M, Bry M, Tammela T, Alitalo K. Lohela M, et al. Curr Opin Cell Biol. 2009 Apr;21(2):154-65. doi: 10.1016/j.ceb.2008.12.012. Epub 2009 Feb 21. Curr Opin Cell Biol. 2009. PMID: 19230644 Review.
Vascular endothelial growth factors and their endothelial tyrosine kinase receptors are central regulators of vasculogenesis, angiogenesis and lymphangiogenesis. ...VEGFR-1 seems to act as a negative regulator of VEGF-mediated a …
Vascular endothelial growth factors and their endothelial tyrosine kinase receptors are central re …
The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF.
Ghalehbandi S, Yuzugulen J, Pranjol MZI, Pourgholami MH. Ghalehbandi S, et al. Eur J Pharmacol. 2023 Jun 15;949:175586. doi: 10.1016/j.ejphar.2023.175586. Epub 2023 Mar 9. Eur J Pharmacol. 2023. PMID: 36906141 Free article. Review.
In spite of its central role in physiological homeostasis, it provides the oxygen and nutrition needed by tumor cells to proceed from dormancy if pro-angiogenic factors tip the balance in favor of tumor angiogenesis. Among pro-angiogenic factors, vascular …
In spite of its central role in physiological homeostasis, it provides the oxygen and nutrition needed by tumor cells to proceed from dorman …
Mechanisms and regulation of endothelial VEGF receptor signalling.
Simons M, Gordon E, Claesson-Welsh L. Simons M, et al. Nat Rev Mol Cell Biol. 2016 Oct;17(10):611-25. doi: 10.1038/nrm.2016.87. Epub 2016 Jul 27. Nat Rev Mol Cell Biol. 2016. PMID: 27461391 Review.
Vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are uniquely required to balance the formation of new blood vessels with the maintenance and remodelling of existing ones, during development and in adult tissues. . …
Vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are uniquely required to …
VEGF as a key mediator of angiogenesis in cancer.
Carmeliet P. Carmeliet P. Oncology. 2005;69 Suppl 3:4-10. doi: 10.1159/000088478. Epub 2005 Nov 21. Oncology. 2005. PMID: 16301830 Review.
Vascular endothelial growth factor (VEGF) is a homodimeric glycoprotein with a molecular weight of approximately 45 kDa. It is the key mediator of angiogenesis (the formation of new blood vessels), and binds two VEGF receptors (VEGF receptor …
Vascular endothelial growth factor (VEGF) is a homodimeric glycoprotein with a molecular weight of approximately 45 kDa …
VEGF receptor signalling - in control of vascular function.
Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. Olsson AK, et al. Nat Rev Mol Cell Biol. 2006 May;7(5):359-71. doi: 10.1038/nrm1911. Nat Rev Mol Cell Biol. 2006. PMID: 16633338 Review.
Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system. VEGFR1 is required for the recruitment of haematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the fu …
Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system. VEGFR1 is required for …
Green tea and its anti-angiogenesis effects.
Rashidi B, Malekzadeh M, Goodarzi M, Masoudifar A, Mirzaei H. Rashidi B, et al. Biomed Pharmacother. 2017 May;89:949-956. doi: 10.1016/j.biopha.2017.01.161. Epub 2017 Mar 8. Biomed Pharmacother. 2017. PMID: 28292023 Review.
The development of new blood vessels from a pre-existing vasculature (also known as angiogenesis) is required for many physiological processes including embryogenesis and post-natal growth. However, pathological angiogenesis is also a hallmark of cancer and m …
The development of new blood vessels from a pre-existing vasculature (also known as angiogenesis) is required for many physiological …
Clinical efficacy and safety of angiogenesis inhibitors: sex differences and current challenges.
Cignarella A, Fadini GP, Bolego C, Trevisi L, Boscaro C, Sanga V, Seccia TM, Rosato A, Rossi GP, Barton M. Cignarella A, et al. Cardiovasc Res. 2022 Mar 16;118(4):988-1003. doi: 10.1093/cvr/cvab096. Cardiovasc Res. 2022. PMID: 33739385 Review.
Vasoactive molecules, such as vascular endothelial growth factor (VEGF) and endothelins, share cytokine-like activities and regulate endothelial cell (EC) growth, migration, and inflammation. Some endothelial mediators and their recept …
Vasoactive molecules, such as vascular endothelial growth factor (VEGF) and endothelins, share cytokine-like activities …
Innate effector cells in angiogenesis and lymphangiogenesis.
Varricchi G, Loffredo S, Galdiero MR, Marone G, Cristinziano L, Granata F, Marone G. Varricchi G, et al. Curr Opin Immunol. 2018 Aug;53:152-160. doi: 10.1016/j.coi.2018.05.002. Epub 2018 May 17. Curr Opin Immunol. 2018. PMID: 29778674 Review.
Vascular endothelial growth factors (VEGFs), angiopoietin (ANGPTs) and a multitude of additional signaling molecules play distinct roles in the modulation of angiogenesis/lymphangiogenesis. VEGFs and ANGPTs activate specific tyrosi …
Vascular endothelial growth factors (VEGFs), angiopoietin (ANGPTs) and a multitude of additional signalin …
14,646 results
You have reached the last available page of results. Please see the User Guide for more information.